Recommendations for Validation of Automated Viable Cell Counting Methods (Review)
Introduction. The quality of viable cell-based products (such as biomedical cell products and advanced therapy medicinal products) must be maintained during the full production cycle to ensure their safety and efficacy for patients. The minimum required number of viable cells is one of the quality c...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | Russian |
| 出版事項: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-12-01
|
| シリーズ: | Разработка и регистрация лекарственных средств |
| 主題: | |
| オンライン･アクセス: | https://www.pharmjournal.ru/jour/article/view/1658 |